Evidence map›Paper›PMID 41022584›Full record

ArticleG3 (Bethesda, Md.)2025

Knockdown of PR-DUB subunit calypso in the developing Drosophila eye and wing results in mis-patterned tissues with altered size and shape.

Max Luf, Priya Begani, Anne M Bowcock, Cathie M Pfleger

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Max LufDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.ORCID 0009-0002-4055-8896
Priya BeganiDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Anne M BowcockDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Cathie M PflegerDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.ORCID 0000-0001-8309-2235

Funding

THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ramon E Parsons · 2015 to 2026
$35.4M
Resource Project CoreU41HG000739 · NHGRI · HARVARD UNIVERSITY · PI PERRIMON, NORBERT · 2014 to 2022
$32.3M
Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
THE GENETICS OF OCULAR MELANOMAR01CA161870 · NCI · WASHINGTON UNIVERSITY · PI BOWCOCK, ANNE MARY · 2011 to 2024
$5.5M
Regulation of Ras in development by post-translational modificationR01GM135330 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI PFLEGER, CATHIE M · 2020 to 2023
$1.4M
Rabex-5 regulation of Ras and Notch signaling in development and diseaseR01GM122995 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI PFLEGER, CATHIE M · 2017 to 2020
$1.3M
Department of Defense Melanoma Research Program ME240338National Institutes of Health, National Institute of General Medical Sciences R01GM122995National Institutes of Health, National Institute of General Medical Sciences R01GM135330NCI NIH HHS P30 CA196521NCI NIH HHS R01 CA161870NCI NIH HHS R01CA161870NHGRI NIH HHS U41 HG000739NIGMS NIH HHS R01 GM122995NIGMS NIH HHS R01 GM135330NIH HHS P40 OD018537
6 · The paper itself

Abstract

The deubiquitinating enzyme BAP1 is the catalytic subunit of the Polycomb Repressive Deubiquitinase (PR-DUB) complex, which acts with the Polycomb Repressive Complexes 1 and 2 to regulate chromatin organization to repress homeotic genes and other developmental regulators. Loss of BAP1 is implicated in several cancers, in the familial cancer syndrome BAP1 Tumor Predisposition Syndrome, and in the neurodevelopmental disorder Küry-Isidor syndrome. In Drosophila, there are numerous reports in the literature describing developmental patterning phenotypes for several chromatin regulators, including the discovery of Polycomb itself, but corresponding adult morphological phenotypes due to developmental dysregulation of the Drosophila BAP1 ortholog calypso (caly) are less well-described. We report here that knockdown of caly in the eye and wing produces concomitant chromatin dysregulation phenotypes. RNAi to caly in the early eye reduces survival and leads to changes in eye size and shape including eye outgrowths, some of which resemble homeotic transformations, whereas others resemble tumor-like outgrowths seen in other fly cancer models. Mosaic eyes containing caly loss-of-function tissue phenocopy caly RNAi. Knocking down caly across the wing disrupts wing shape and patterning, including effects on wing vein pattern. This phenotypic characterization reinforces the growing body of literature detailing developmental mis-patterning driven by chromatin dysregulation and serves as a baseline for future mechanistic studies to understand the role of BAP1 in development and disease.

Indexed as

Body PatterningDeubiquitinating EnzymesDrosophilaDrosophila melanogasterDrosophila ProteinsEyeUbiquitin ThiolesteraseWings, AnimalAnimalsGene Expression Regulation, DevelopmentalGene Knockdown TechniquesPhenotypeDeubiquitinating EnzymesDrosophila ProteinsUbiquitin ThiolesteraseBAP1calypsoDrosophilapolycomb repressionPR-DUB

Identifiers

PMID41022584
PMCPMC12693516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.